Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mesoblast Ltd (NASDAQ:MESO)

3.98
Delayed Data
As of Jun 29
 +0.09 / +2.31%
Today’s Change
3.50
Today|||52-Week Range
15.56
-37.42%
Year-to-Date
No recent news for Mesoblast Ltd.

Today’s Trading

Previous close3.89
Today’s open4.00
Day’s range3.83 - 4.00
Volume59,858
Average volume (3 months)53,891
Market cap$259.8M
Dividend yield--
Data as of 06/29/2016

Growth & Valuation

Earnings growth (last year)-33.20%
Earnings growth (this year)+25.03%
Earnings growth (next 5 years)-0.34%
Revenue growth (last year)+13.25%
P/E ratio--
Price/Sales54.36
Price/Book0.55

Competitors

 Today’s
change
Today’s
% change
CFMSConforMIS Inc+0.32+4.98%
RTIXRTI Surgical Inc0.000.00%
IVCInvacare Corp+0.80+7.14%
DSCIDerma Sciences Inc+0.01+0.26%
Data as of 06/29/2016

Financials

Next reporting dateAugust 23, 2016
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$17.1M
Annual profit (last year)-$99.4M
Net profit margin-582.77%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, Executive Director &
MD
Silviu Itescu
Chief Financial Officer
Paul Hodgkinson
Corporate headquarters
Melbourne, Victoria (vic)

Forecasts

Partner Offers

Search for Jobs